Drawing for VIRAFREE MOISTURISING TECHNOLOGY

USPTO serial 79347067

VIRAFREE MOISTURISING TECHNOLOGY

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
LAMONT, JOHN CHRISTOPHER
Law office
TMO LAW OFFICE 123 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIRAFREE MOISTURISING TECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Disinfectants and antiseptics; medicated and sanitizing soaps and detergents, and articles especially adapted for application of medicated and sanitizing soaps and medicated and sanitizing detergents (term considered too vague by the International Bureau - rule 13 (2) (b) of the Regulations); hand sanitizing and hand disinfecting preparations, including preparations with moisturizing properties; antibacterial, antiviral and antimicrobial preparations, including preparations with moisturizing properties; antibacterial lotions, gels, rubs and sprays, including antibacterial, antiviral or antimicrobial hand lotions, hand gels, hand rubs and sprays; alcohol-based antibacterial gels; dispensers especially adapted for antibacterial, antiviral and antimicrobial preparations, including dispensers especially adapted for sanitizing lotions, gels, rubs and sprays (term considered too vague by the International Bureau - rule 13 (2) (b) of the Regulations); wipes, including sanitizing wipes, antibacterial wipes, antiviral wipes, impregnated antiseptic wipes, disposable sanitizing wipes; nasal applications, nasal rinse, nasal spray, nasal spray preparations, nasal sprays for medical purposes, nasal dispensersSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 16, 2023DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
May 15, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 6, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 6, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 6, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 12, 2022RFNTREFUSAL PROCESSED BY IB—
Aug 21, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 21, 2022RFRRREFUSAL PROCESSED BY MPU—
Aug 16, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 16, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 15, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 12, 2022DOCKASSIGNED TO EXAMINER—
Aug 12, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 11, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance